Ortho Clinical Diagnostics Products

Introducing the ORTHO VISION™ Analyzer—the system with the power to transform transfusion medicine The ORTHO VISION™ Analyzer was developed to meet the unique needs of immunohematology labs through the proprietary benefits of Responsive ... Read more...

Providing fast, accurate results is a necessity—even for small labs—with growing pressure to reduce errors and cut costs in the midst of increased demands and significant staffing shortages. The VITROS ®  350 Sys... Read more...

Immunohematology The first fully automated blood bank instrument for the North American market to be based on the ID-MTS™ Gel Test™. Operational Improvement – Eliminate labor-intensive, time-consuming processes while increasing produ... Read more...

VITROS HIV Combo, a fourth-generation test, detects both HIV-1 and HIV-2 antibodies (Ab) and the p24 antigen (Ag), enabling HIV-1 acute infection detection earlier than third-generation tests Read more...

Every day, labs like yours face the challenge of improving patient care while balancing staffing, compliance, and total operating cost containment. With proven technologies and a comprehensive chemistry menu for both routine and sp... Read more...

Precision and accuracy are critical in labs of any size. The ORTHO™ Workstation is the only compact 2-in-1 blood testing system with reliable ID-Micro Typing System™ (ID-MTS™) Gel Column Agglutination Technology (CAT). I... Read more...

VITROS ®  XT Systems embrace digital chemistry and are powered by a new digital reflectometer, connecting your lab's ecosystem better than ever before, driving your efficiency, productivity and improving the quality of care y... Read more...

How it works: VITROS ® MicroSlide Technology offers an entire integrated test environment on a thin piece of film. Spreading, masking, scavenger, and reagent layers are discretely combined on one postage-stamp-sized slide to p... Read more...

Novel Biomarker Identification. Rapid Risk Assessment. The innovative end result of Astute Medical's novel biomarker identification, the NephroCheck® Test provides risk assessment of critically ill patients who may develop acute kidne... Read more...